359 related articles for article (PubMed ID: 29416121)
21. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
22. Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates.
Stein C; Makarewicz O; Bohnert JA; Pfeifer Y; Kesselmeier M; Hagel S; Pletz MW
PLoS One; 2015; 10(6):e0126479. PubMed ID: 26067824
[TBL] [Abstract][Full Text] [Related]
23. Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline.
Chen A; Smith KP; Whitfield BA; Zucchi PC; Lasco TM; Bias TE; Kirby JE; Hirsch EB
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):365-367. PubMed ID: 28535946
[TBL] [Abstract][Full Text] [Related]
24. Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species.
Haidar G; Alkroud A; Cheng S; Churilla TM; Churilla BM; Shields RK; Doi Y; Clancy CJ; Nguyen MH
Antimicrob Agents Chemother; 2016 Sep; 60(9):5208-14. PubMed ID: 27297487
[TBL] [Abstract][Full Text] [Related]
25. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae.
Elemam A; Rahimian J; Doymaz M
J Clin Microbiol; 2010 Oct; 48(10):3558-62. PubMed ID: 20686085
[TBL] [Abstract][Full Text] [Related]
26. In vitro antibacterial activity of fosfomycin combined with other antimicrobials against KPC-producing Klebsiella pneumoniae.
Yu W; Shen P; Bao Z; Zhou K; Zheng B; Ji J; Guo L; Huang C; Xiao Y
Int J Antimicrob Agents; 2017 Aug; 50(2):237-241. PubMed ID: 28648647
[TBL] [Abstract][Full Text] [Related]
27. Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York City.
Manning N; Balabanian G; Rose M; Landman D; Quale J
Microb Drug Resist; 2018; 24(1):35-39. PubMed ID: 28590820
[TBL] [Abstract][Full Text] [Related]
28. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
30. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.
Bratu S; Tolaney P; Karumudi U; Quale J; Mooty M; Nichani S; Landman D
J Antimicrob Chemother; 2005 Jul; 56(1):128-32. PubMed ID: 15917285
[TBL] [Abstract][Full Text] [Related]
31. Preliminary Study on the Antibacterial Activity of Essential Oils Alone and in Combination with Gentamicin Against Extended-Spectrum β-Lactamase-Producing and New Delhi Metallo-β-Lactamase-1-Producing Klebsiella pneumoniae Isolates.
Kwiatkowski P; Pruss A; Grygorcewicz B; Wojciuk B; Dołęgowska B; Giedrys-Kalemba S; Kochan E; Sienkiewicz M
Microb Drug Resist; 2018 Nov; 24(9):1368-1375. PubMed ID: 29708847
[TBL] [Abstract][Full Text] [Related]
32. Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae.
Diep JK; Jacobs DM; Sharma R; Covelli J; Bowers DR; Russo TA; Rao GG
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872078
[TBL] [Abstract][Full Text] [Related]
33. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
34. Synergistic Activity of Colistin/Fosfomycin Combination against Carbapenemase-Producing
Wang J; He JT; Bai Y; Wang R; Cai Y
Biomed Res Int; 2018; 2018():5720417. PubMed ID: 29850537
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae.
Poirel L; Kieffer N; Nordmann P
J Antimicrob Chemother; 2016 Jan; 71(1):156-61. PubMed ID: 26416781
[TBL] [Abstract][Full Text] [Related]
36. Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains.
Morici P; Florio W; Rizzato C; Ghelardi E; Tavanti A; Rossolini GM; Lupetti A
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1739-1748. PubMed ID: 28470337
[TBL] [Abstract][Full Text] [Related]
37. KPC-producing Klebsiella pneumoniae bloodstream isolates from Brazilian hospitals: What (still) remains active?
Antochevis LC; Magagnin CM; Nunes AG; Goulart TM; Martins AS; Cayô R; Gales AC; Barth AL; Zavascki AP
J Glob Antimicrob Resist; 2018 Dec; 15():173-177. PubMed ID: 30071353
[TBL] [Abstract][Full Text] [Related]
38. Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.
Clancy CJ; Chen L; Hong JH; Cheng S; Hao B; Shields RK; Farrell AN; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
Antimicrob Agents Chemother; 2013 Nov; 57(11):5258-65. PubMed ID: 23939888
[TBL] [Abstract][Full Text] [Related]
39. Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.
Jacobs DM; Safir MC; Huang D; Minhaj F; Parker A; Rao GG
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):76. PubMed ID: 29178957
[TBL] [Abstract][Full Text] [Related]
40. An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones.
Bonura C; Giuffrè M; Aleo A; Fasciana T; Di Bernardo F; Stampone T; Giammanco A; ; Palma DM; Mammina C
PLoS One; 2015; 10(7):e0132936. PubMed ID: 26177547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
